What's Behind Teva's Mixed Q1 Results

Teva Pharmaceuticals (NYSE: TEVA) started off 2021 with a bang. Its shares soared more than 30% during the first few weeks of the year. Since then, though, Teva has given up most of those gains.

The company had an opportunity for a catalyst when Teva announced its first-quarter results before the market opened on Wednesday. However, those results didn't spark a rebound: The pharmaceutical stock slipped almost 3% in early trading. Here are the highlights from Teva's Q1 update.

Image source: Getty Images.

Source Fool.com